177Lu‐Gold Nanohybrids in Radiotherapeutic Approaches Against Cancer

Internal radionuclide therapy using lutetium‐177 (177Lu)‐based radiopharmaceuticals has emerged as a promising approach in the field of nuclear medicine and oncology. Combining the radioactive lanthanide with high atomic number metal nanoparticles such as gold potentiates the radiotoxicity of luteti...

Full description

Saved in:
Bibliographic Details
Main Authors: Mathilde Ponchelle, Marek Pruszyński, Edmond Gravel, Eric Doris
Format: Article
Language:English
Published: Wiley-VCH 2025-05-01
Series:Small Science
Subjects:
Online Access:https://doi.org/10.1002/smsc.202400550
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849314342894305280
author Mathilde Ponchelle
Marek Pruszyński
Edmond Gravel
Eric Doris
author_facet Mathilde Ponchelle
Marek Pruszyński
Edmond Gravel
Eric Doris
author_sort Mathilde Ponchelle
collection DOAJ
description Internal radionuclide therapy using lutetium‐177 (177Lu)‐based radiopharmaceuticals has emerged as a promising approach in the field of nuclear medicine and oncology. Combining the radioactive lanthanide with high atomic number metal nanoparticles such as gold potentiates the radiotoxicity of lutetium by an amplification process. 177Lu‐gold nanohybrids have been investigated by various research groups, both in vitro and in vivo, to decipher the physicochemical, radiochemical, and biological factors that would enable selective and optimal dose deposition in tumors. This review focuses on 177Lu‐gold tailored approaches that are developed in the literature to locally enhance internal radiotherapeutic effects.
format Article
id doaj-art-2bfce3779b6d444691ac6a862f34fa6b
institution Kabale University
issn 2688-4046
language English
publishDate 2025-05-01
publisher Wiley-VCH
record_format Article
series Small Science
spelling doaj-art-2bfce3779b6d444691ac6a862f34fa6b2025-08-20T03:52:29ZengWiley-VCHSmall Science2688-40462025-05-0155n/an/a10.1002/smsc.202400550177Lu‐Gold Nanohybrids in Radiotherapeutic Approaches Against CancerMathilde Ponchelle0Marek Pruszyński1Edmond Gravel2Eric Doris3Université Paris‐Saclay, CEA, INRAE Département Médicaments et Technologies pour la Santé (DMTS), SCBM 91191 Gif‐sur‐Yvette FranceNOMATEN Centre of Excellence National Centre for Nuclear Research 05‐400 Otwock PolandUniversité Paris‐Saclay, CEA, INRAE Département Médicaments et Technologies pour la Santé (DMTS), SCBM 91191 Gif‐sur‐Yvette FranceUniversité Paris‐Saclay, CEA, INRAE Département Médicaments et Technologies pour la Santé (DMTS), SCBM 91191 Gif‐sur‐Yvette FranceInternal radionuclide therapy using lutetium‐177 (177Lu)‐based radiopharmaceuticals has emerged as a promising approach in the field of nuclear medicine and oncology. Combining the radioactive lanthanide with high atomic number metal nanoparticles such as gold potentiates the radiotoxicity of lutetium by an amplification process. 177Lu‐gold nanohybrids have been investigated by various research groups, both in vitro and in vivo, to decipher the physicochemical, radiochemical, and biological factors that would enable selective and optimal dose deposition in tumors. This review focuses on 177Lu‐gold tailored approaches that are developed in the literature to locally enhance internal radiotherapeutic effects.https://doi.org/10.1002/smsc.202400550gold nanoparticleslutetium‐177nanomedicinesradioenhancementradiopharmaceuticals
spellingShingle Mathilde Ponchelle
Marek Pruszyński
Edmond Gravel
Eric Doris
177Lu‐Gold Nanohybrids in Radiotherapeutic Approaches Against Cancer
Small Science
gold nanoparticles
lutetium‐177
nanomedicines
radioenhancement
radiopharmaceuticals
title 177Lu‐Gold Nanohybrids in Radiotherapeutic Approaches Against Cancer
title_full 177Lu‐Gold Nanohybrids in Radiotherapeutic Approaches Against Cancer
title_fullStr 177Lu‐Gold Nanohybrids in Radiotherapeutic Approaches Against Cancer
title_full_unstemmed 177Lu‐Gold Nanohybrids in Radiotherapeutic Approaches Against Cancer
title_short 177Lu‐Gold Nanohybrids in Radiotherapeutic Approaches Against Cancer
title_sort 177lu gold nanohybrids in radiotherapeutic approaches against cancer
topic gold nanoparticles
lutetium‐177
nanomedicines
radioenhancement
radiopharmaceuticals
url https://doi.org/10.1002/smsc.202400550
work_keys_str_mv AT mathildeponchelle 177lugoldnanohybridsinradiotherapeuticapproachesagainstcancer
AT marekpruszynski 177lugoldnanohybridsinradiotherapeuticapproachesagainstcancer
AT edmondgravel 177lugoldnanohybridsinradiotherapeuticapproachesagainstcancer
AT ericdoris 177lugoldnanohybridsinradiotherapeuticapproachesagainstcancer